ArticleJournal of Cancer2019

Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status.

Hideyuki Katsura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.